Displaying 10 out of 21 results

  1. A woman undergoes a mammogram

    Most women need mammograms every other year starting at 50

  2. FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield

    AstraZeneca pays up to US$6.9 billion in Daiichi Sankyo cancer deal

    AstraZeneca Plc and Japan's Daiichi Sankyo Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Daiichi's cancer ...
  3. New Content Item

    Breast cancer risk tied to DDT varies by exposure timing

  4. Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche's Tecentriq wins US approval for aggressive breast cancer

    Swiss drugmaker Roche on Friday won U.S. Food and Drug Administration (FDA) approval of its immunotherapy Tecentriq for triple-negative breast ...
  5. FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Ba

    Roche's Tecentriq wins fast FDA review in tough-to-treat breast cancer

    Roche's Tecentriq medicine will get a speedy review by U.S. regulators in a tough-to-treat form of breast cancer as the Swiss drugmaker seeks to ...
  6. FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Ba

    Roche scores win in slowing aggressive type of breast cancer

    An immunotherapy cocktail from Roche helped slow a type of breast cancer where new treatments have proven elusive, data released on Saturday ...
  7. Logo of U.S. pharmaceutical corporation Pfizer Inc. is seen in Zurich

    FDA approves Pfizer's breast cancer drug

    The U.S. Food and Drug Administration said on Tuesday it approved Pfizer Inc's drug for advanced form of breast cancer.
  8. Breast cancer caregiver Breast Cancer Foundation Low Sie Chong Eunice Tan

    Through sickness and health: Why caregivers of breast cancer patients need support too

    CNA Lifestyle speaks to two families about their breast cancer journeys – the unwavering love and support that's needed for both patient and ...
  9. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Novartis trial win lifts profile of new breast cancer drug

    Novartis's efforts to tackle an elusive gene mutation behind tough-to-treat breast cancer were rewarded on Thursday, as the Swiss drugmaker said ...